We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
National CineMedia
NCMI
$378M
| $435K | ﹤0.01% |
96,461
-2,716
| -3% | -$12.7K |
|
2652
Omeros
OMER
$959M
| $434K | ﹤0.01% |
105,873
+7,048
| +7% | +$28K |
|
|
CIO
2653
DELISTED
City Office REIT
CIO
| $434K | ﹤0.01% |
62,340
-6,648
| -10% | -$43.9K |
|
2654
Organogenesis Holdings
ORGO
$239M
| $433K | ﹤0.01% |
102,530
-2,682
| -3% | -$12.5K |
|
|
ARDT
2655
Ardent Health
ARDT
$1.66B
| $433K | ﹤0.01% |
32,652
-578
| -2% | -$7.23K |
|
2656
Ooma
OOMA
$604M
| $432K | ﹤0.01% |
36,040
-1,717
| -5% | -$21K |
|
2657
Monopar Therapeutics
MNPR
$799M
| $432K | ﹤0.01% |
5,288
-562
| -10% | -$25.1K |
|
2658
Nathan's Famous
NATH
$402M
| $431K | ﹤0.01% |
3,895
-143
| -4% | -$15K |
|
2659
Logitech
LOGI
$15.2B
| $430K | ﹤0.01% |
3,922
-810
| -17% | -$81.4K |
|
2660
Bioventus
BVS
$1.19B
| $430K | ﹤0.01% |
64,275
-818
| -1% | -$5.68K |
|
2661
Cerus
CERS
$474M
| $429K | ﹤0.01% |
269,549
+603
| +0.2% | +$814 |
|
2662
Greif Class B
GEF.B
$4.21B
| $428K | ﹤0.01% |
6,955
-348
| -5% | -$23.4K |
|
|
ELP
2663
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $428K | ﹤0.01% |
43,668
-3,727
| -8% | -$33.5K |
|
|
NTT
2664
DELISTED
Nippon Telegraph & Telephone
NTT
| $427K | ﹤0.01% |
16,394
-6,441
| -28% | -$168K |
|
2665
Nokia
NOK
$52.3B
| $427K | ﹤0.01% |
88,760
-16,416
| -16% | -$74.2K |
|
2666
Aura Biosciences
AURA
$826M
| $427K | ﹤0.01% |
69,037
+3,630
| +6% | +$23.7K |
|
2667
Cullinan Oncology
CGEM
$1.14B
| $426K | ﹤0.01% |
71,809
-2,296
| -3% | -$16.8K |
|
2668
Distribution Solutions Group
DSGR
$1.61B
| $426K | ﹤0.01% |
14,156
+49
| +0.3% | +$1.5K |
|
2669
W&T Offshore
WTI
$518M
| $426K | ﹤0.01% |
233,933
-19,945
| -8% | -$35.4K |
|
2670
Vanda Pharmaceuticals
VNDA
$302M
| $426K | ﹤0.01% |
85,293
-1,253
| -1% | -$5.8K |
|
2671
Editas Medicine
EDIT
$442M
| $425K | ﹤0.01% |
122,526
-4,273
| -3% | -$11.9K |
|
2672
Natural Gas Services Group
NGS
$477M
| $424K | ﹤0.01% |
15,159
-1,611
| -10% | -$41.3K |
|
2673
Cadiz
CDZI
$291M
| $424K | ﹤0.01% |
89,862
-2,101
| -2% | -$7.34K |
|
2674
Spire Global
SPIR
$555M
| $423K | ﹤0.01% |
38,512
-728
| -2% | -$7.52K |
|
2675
American Battery Technology Co
ABAT
$356M
| $422K | ﹤0.01% |
86,929
+11,993
| +16% | +$31.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.